Istituto Lusofarmaco

Istituto Lusofarmaco is a long-standing Italian pharmaceutical company based in Milan and a member of the Menarini Group since 1983. The company specializes in the development and commercialization of therapeutic products, with a historical focus on cardiovascular health, respiratory medicine, and pain management. It is particularly recognized for its portfolio of cardiovascular treatments, including the ACE inhibitor zofenopril. As a subsidiary of Italy's largest pharmaceutical group, Lusofarmaco operates within a robust international network of research, development, and manufacturing. The company continues to be a significant player in the Italian market, providing essential medicines for chronic and acute conditions.